The John F. DiPersio Immunotherapy Symposium will take place on Wednesday March 27, 2024. The symposium honors John DiPersio’s contributions to the understanding of the pathogenesis of and development of new treatments for hematopoietic malignancies.
The symposium will feature presentations by three leaders in the field of cancer immunotherapy. Dr. Stanley Riddell (Fred Hutchinson Cancer Research Center) will discuss strategies to optimize the use of T cell immunotherapy based. Dr. Jedd Wolchok (Weill Cornell) will discuss recent work to augment immune checkpoint blockade for the treatment of melanoma. Finally, Dr. Carl June (University of Pennsylvania) will present his ground-breaking research on enhancing CAR T cell therapies.